It has also been demonstrated that cancer cells that undergo through epithelial to mesenchymal transition (EMT) acquire a basal CD44+/CD24low/− cancer stem-like phenotype with increased capacity for self-renewal, invasion, drug resistance, and tumor progression [11]. Here, CD44 is linked to cancer.